Looking into the clinical application of CD47-targeted near-infrared photoimmunotherapy for human bladder cancer treatment.
作者信息
Kim Jayoung
机构信息
Department of Surgery and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Department of Medicine, University of California Los Angeles, CA, USA.
出版信息
Transl Androl Urol. 2019 Jul;8(Suppl 3):S322-S324. doi: 10.21037/tau.2019.05.13.
Abstract
摘要
相似文献
1
Looking into the clinical application of CD47-targeted near-infrared photoimmunotherapy for human bladder cancer treatment.探讨CD47靶向近红外光免疫疗法在人类膀胱癌治疗中的临床应用。
Transl Androl Urol. 2019 Jul;8(Suppl 3):S322-S324. doi: 10.21037/tau.2019.05.13.
2
CD47-Targeted Near-Infrared Photoimmunotherapy for Human Bladder Cancer.CD47 靶向近红外光免疫治疗人膀胱癌。
Clin Cancer Res. 2019 Jun 15;25(12):3561-3571. doi: 10.1158/1078-0432.CCR-18-3267. Epub 2019 Mar 19.
3
CD47-targeted optical molecular imaging and near-infrared photoimmunotherapy in the detection and treatment of bladder cancer.靶向CD47的光学分子成像及近红外光免疫疗法在膀胱癌检测与治疗中的应用
Mol Ther Oncolytics. 2022 Jan 1;24:319-330. doi: 10.1016/j.omto.2021.12.020. eCollection 2022 Mar 17.
4
Multimodal near-infrared molecular imaging of ex vivo endometrial carcinoma via CD47-based targeted tracer.通过基于CD47的靶向示踪剂对离体子宫内膜癌进行多模态近红外分子成像。
Bioeng Transl Med. 2025 Feb 4;10(3):e10754. doi: 10.1002/btm2.10754. eCollection 2025 May.
5
near-infrared targeted imaging of human bladder carcinoma by ICG-anti-CD47.吲哚菁绿-抗CD47对人膀胱癌的近红外靶向成像
Front Oncol. 2023 Mar 1;13:1083553. doi: 10.3389/fonc.2023.1083553. eCollection 2023.
6
Near-infrared photoimmunotherapy targeting Nectin-4 in a preclinical model of bladder cancer.近红外光免疫治疗膀胱癌模型中 Nectin-4 的研究。
Cancer Lett. 2024 Mar 31;585:216606. doi: 10.1016/j.canlet.2023.216606. Epub 2024 Jan 23.
7
Tissue factor targeted near-infrared photoimmunotherapy: a versatile therapeutic approach for malignancies.组织因子靶向近红外光免疫疗法：一种用于恶性肿瘤的通用治疗方法。
Cancer Immunol Immunother. 2025 Jan 3;74(2):48. doi: 10.1007/s00262-024-03903-2.
8
Near-Infrared Molecular Imaging of Human Upper Urinary Tract Urothelial Carcinoma With a CD47-Based Targeted Tracer.基于CD47的靶向示踪剂对人上尿路尿路上皮癌的近红外分子成像
Front Oncol. 2022 Feb 28;12:825476. doi: 10.3389/fonc.2022.825476. eCollection 2022.
9
Intercellular adhesion molecule-1-targeted near-infrared photoimmunotherapy of triple-negative breast cancer.细胞间黏附分子-1 靶向近红外光免疫治疗三阴性乳腺癌。
Cancer Sci. 2022 Sep;113(9):3180-3192. doi: 10.1111/cas.15466. Epub 2022 Jul 11.
10
Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.表皮生长因子受体（EGFR）靶向光免疫疗法（PIT）治疗 EGFR 表达的膀胱癌。
Mol Cancer Ther. 2017 Oct;16(10):2201-2214. doi: 10.1158/1535-7163.MCT-16-0924. Epub 2017 Jun 15.
本文引用的文献
1
CD47-Targeted Near-Infrared Photoimmunotherapy for Human Bladder Cancer.CD47 靶向近红外光免疫治疗人膀胱癌。
Clin Cancer Res. 2019 Jun 15;25(12):3561-3571. doi: 10.1158/1078-0432.CCR-18-3267. Epub 2019 Mar 19.
2
Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT).采用联合光免疫疗法（PIT）靶向表皮生长因子受体（EGFR）和人表皮生长因子受体 2（HER2）表达的膀胱癌。
Sci Rep. 2019 Feb 14;9(1):2084. doi: 10.1038/s41598-019-38575-x.
3
Nanotechnology-based photoimmunological therapies for cancer.基于纳米技术的光免疫疗法治疗癌症。
Cancer Lett. 2019 Feb 1;442:429-438. doi: 10.1016/j.canlet.2018.10.044. Epub 2018 Nov 24.
4
Photodynamic Therapy in the Treatment of Bladder Cancer: Past Challenges and Current Innovations.光动力疗法在膀胱癌治疗中的应用：过去的挑战与当前的创新。
Eur Urol Focus. 2018 Jul;4(4):509-511. doi: 10.1016/j.euf.2018.08.005. Epub 2018 Aug 23.
5
O-generating MnO nanoparticles for enhanced photodynamic therapy of bladder cancer by ameliorating hypoxia.生成用于改善缺氧以增强膀胱癌光动力治疗的 MnO 纳米颗粒。
Theranostics. 2018 Jan 1;8(4):990-1004. doi: 10.7150/thno.22465. eCollection 2018.
6
Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.表皮生长因子受体（EGFR）靶向光免疫疗法（PIT）治疗 EGFR 表达的膀胱癌。
Mol Cancer Ther. 2017 Oct;16(10):2201-2214. doi: 10.1158/1535-7163.MCT-16-0924. Epub 2017 Jun 15.
7
Super enhanced permeability and retention (SUPR) effects in tumors following near infrared photoimmunotherapy.近红外光免疫治疗后肿瘤中超增强通透性和保留（SUPR）效应。
Nanoscale. 2016 Jul 7;8(25):12504-9. doi: 10.1039/c5nr05552k. Epub 2015 Oct 7.
8
Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancer.缺氧诱导因子-1α 的表达预测浸润性膀胱癌缺氧修饰获益。
Br J Cancer. 2014 Jul 29;111(3):437-43. doi: 10.1038/bjc.2014.315. Epub 2014 Jun 17.
9
Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer.缺氧通过 HIF-1α 和 miR-100 调节 FGFR3 的表达，并有助于非肌肉浸润性膀胱癌中的细胞存活。
Br J Cancer. 2013 Jul 9;109(1):50-9. doi: 10.1038/bjc.2013.240. Epub 2013 Jun 18.
10
From patient to discoverer--Niels Ryberg Finsen (1860–1904) --the founder of phototherapy in dermatology.从患者到发现者——尼尔·吕贝格·芬森（1860 年至 1904 年）——皮肤病光疗的奠基人。
Clin Dermatol. 2012 Jul-Aug;30(4):451-5. doi: 10.1016/j.clindermatol.2011.11.019.
Zotero 插件